Tevogen (TVGN) Other Accumulated Expenses (2022 - 2026)
Tevogen (TVGN) reported Other Accumulated Expenses of $98,830 for Q1 2026, down 78.7% from $463,587 a year earlier and down 70.1% from the prior quarter.
Powered by 
Analysis
Tevogen (TVGN) Other Accumulated Expenses (2022 - 2026) Analysis & Trends
At the end of FY2025, Tevogen posted Other Accumulated Expenses of $331,086, down 17.9% from FY2024.
- Other Accumulated Expenses has a three-year compound annual growth rate of 33.2% (FY2022 to FY2025).
- By year, Other Accumulated Expenses came in at $403,233 in FY2024 (+235.6%), $120,149 in FY2023 (-14.2%) and $140,000 in FY2022.
- Five-year quarterly Other Accumulated Expenses spans a low of $61,307 in Q3 2024 and a high of $463,587 in Q1 2025.
- Year over year, Other Accumulated Expenses gained in four of the last eight quarters, with growth averaging 59.9%.
- The high point for year-over-year Other Accumulated Expenses in five years was Q3 2025 (growth of 292.0%); the low point was Q2 2025 (a decline of 80.7%).
- Per Business Quant data, the three quarters before Q1 2026 came in at $331,086 (Q4 2025), $240,296 (Q3 2025) and $75,006 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Tevogen | 27.39 Mn | 24.42 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 98,830.00 |
| Dec 31, 2025 | 331,086.00 |
| Sep 30, 2025 | 240,296.00 |
| Jun 30, 2025 | 75,006.00 |
| Mar 31, 2025 | 463,587.00 |
| Dec 31, 2024 | 403,233.00 |
| Sep 30, 2024 | 61,307.00 |
| Jun 30, 2024 | 388,601.00 |
| Mar 31, 2024 | 227,246.00 |
| Dec 31, 2023 | 120,149.00 |
| Sep 30, 2023 | 200,000.00 |
| Jun 30, 2023 | 200,000.00 |
| Dec 31, 2022 | 140,000.00 |
API Access
Tevogen Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=TVGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "TVGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=TVGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();